MACROCYCLIC QUINOXALINE COMPOUNDS AS HCV NS3 PROTEASE INHIBITORS
摘要
The present invention relates to a macrocyclic compound of formula (I) useful as inhibitors of the hepatitis C virus (HCV) NS3 protease, and in treating or preventing HCV infections, in combination with other therapeutic agents.
申请公布号
HUS1700001(I1)
申请公布日期
2017.02.28
申请号
HUS1700001C
申请日期
2017.01.10
申请人
Instituto di Richerche di Biologia Moleculare P. Angeletti S.R.L.;Merck Sharp & Dohme Corp.
